Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
OTC Drugs

GMP Compliance Builds As Industry Priority While FDA Sorts Out Its Own

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

The good manufacturing practices final rule rarely slips from the top of dietary supplement manufacturers' priority lists, but the rule apparently has not occupied the same level of attention with agency staff members who inspect manufacturing facilities
Table

View full table

Advertisement

Related Content

Pink Sheet
FDA's Frankos Grades GMP Complaint Recordkeeping "Needs Improvement"
Pink Sheet
FDA's Frankos Grades GMP Complaint Recordkeeping "Needs Improvement"
HBW Insight
FDA's Frankos Grades GMP Complaint Recordkeeping "Needs Improvement"
Pink Sheet
GMP Inspections Under Way in Southwest Region: “Be Ready,” Says FDA
Pink Sheet
GMP Inspections Under Way in Southwest Region: “Be Ready,” Says FDA
HBW Insight
GMP Inspections Under Way in Southwest Region: “Be Ready,” Says FDA
Pink Sheet
Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing
Pink Sheet
Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing

Topics

Advertisement
Tags:
OTC Drugs
UsernamePublicRestriction

Register

PS101919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By